ARCH Venture Partners VIII, LLC's Net Worth
$720 Million
Who is ARCH Venture Partners VIII, LLC?
ARCH Venture Partners VIII, LLC has an estimated net worth of $720 Million. This is based on reported shares across multiple companies, which include Neumora Therapeutics, Inc., Scholar Rock Holding Corp, Quanterix Corp, Denali Therapeutics Inc., Twist Bioscience Corp, Metacrine, Inc., Unity Biotechnology, Inc., Codiak BioSciences, Inc., Sienna Biopharmaceuticals, Inc., and Homology Medicines, Inc..
SEC CIK
ARCH Venture Partners VIII, LLC's CIK is 0001616165
Past Insider Trading and Trends
2018 was ARCH Venture Partners VIII, LLC's most active year for acquiring shares with 18 total transactions. ARCH Venture Partners VIII, LLC's most active month to acquire stocks was the month of August. 2018 was ARCH Venture Partners VIII, LLC's most active year for disposing of shares, totalling 17 transactions. ARCH Venture Partners VIII, LLC's most active month to dispose stocks was the month of April. 2023 saw ARCH Venture Partners VIII, LLC paying a total of $25,500,000.00 for 18,924,704 shares, this is the most they've acquired in one year. In 2020 ARCH Venture Partners VIII, LLC cashed out on 30,643,367 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Scholar Rock Holding Corp (SRRK) Snapshot price: $16.06
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.64M |
—
|
—
| 2.64M |
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Denali Therapeutics Inc. (DNLI) Snapshot price: $16.61
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.61% | -400.00K |
—
|
—
| 10.67M |
Aug 8
| |||
Form 4
| +3,442.00% | 10.76M |
—
|
—
| 11.07M |
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Metacrine, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.94M |
$13.00 |
—
| 2.94M |
Sep 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Unity Biotechnology, Inc. (UBX) Snapshot price: $1.7389
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +25,308.20% | 10.01M |
—
|
—
| 10.05M |
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Codiak BioSciences, Inc. (CDAKQ) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +129.73% | 5M |
$1.50 | $7,500,000.00 | 8.85M |
Sep 13
| |||
Form 4
| +75.61% | 3.79M |
$15.00 | $3,525,000.00 | 8.8M |
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |